Skip to main content
Total HealthSupply
Lidocaine Hydrochloride Injection, USP, 1% (10 mg / mL), 50 mL Multiple-Dose Vial – Vial (EA/1)
Available to order

Lidocaine Hydrochloride Injection, USP, 1% (10 mg / mL), 50 mL Multiple-Dose Vial – Vial (EA/1)

SKU HIK 00143957710-EA

$5.75

Packaging: 10 Vials per Carton. Confirm the selling unit with customer care before ordering if unclear.

Purchase options

Request quote
Brand
Hikma Pharmaceuticals USA

Product details

Product Specifications

Specification Details
Manufacturer / Brand Hikma Pharmaceuticals USA
Manufacturer # / SKU 00143957710
NDC Number 00143-9577-10
Active Ingredient Lidocaine Hydrochloride
Strength 1% (10 mg / mL)
Volume per Unit 50 mL
Container Type Multiple-Dose Vial (MDV)
Formulation Contains Methylparaben (Preserved)
Storage Temperature 20°C to 25°C (68°F to 77°F)
Packaging 10 Vials per Carton
Latex Content Not made with natural rubber latex

Key Features & Clinical Applications

  • Versatile Anesthesia: Indicated for percutaneous infiltration, peripheral nerve blocks (e.g., brachial plexus, intercostal), and central neural techniques (epidural and caudal blocks).

  • Multiple-Dose Format: The inclusion of methylparaben provides antimicrobial protection, making it ideal for procedures requiring varying volumes across multiple administrations.

  • Rapid Onset: Provides fast-acting local anesthesia with a medium duration of action (typically 1 to 2 hours).

  • Standard Concentration: The 1% (10 mg/mL) concentration is the clinical standard for most infiltration and nerve block procedures.

  • Reliable Generic: Recognized as a high-quality, bioequivalent generic to Xylocaine®.

⚠️ Usage Note: Not for Epidural or Caudal Use. Formulations containing preservatives (like methylparaben) must not be used for spinal or epidural anesthesia, or for any route of administration that would introduce the solution into the cerebrospinal fluid.

⚠️ Safety Alert: Systemic Toxicity. Injections should be made slowly with frequent aspiration to avoid accidental intravascular injection, which can lead to central nervous system toxicity or cardiovascular collapse.

⚠️ Emergency Readiness: Local anesthetics should only be administered by clinicians well-versed in the management of dose-related toxicity. Ensure immediate availability of oxygen and resuscitative drugs.